1. The Top 10 Causes of Death in 2014, Fact Sheet of WHO Report. World Health Organization, 2008.
2. Goya M. Iranian Annual Cancer Registration Report 2015/2016. Ministry of Health and Medical Education, Health Deputy, Center for Disease Control and Prevention (In Persian). Tehran, Iran, 2007.
3. Benider A, Harif M, Karkouri M et al. Registre des cancers de la region du grand Casablanca (2005.2006.2007). Association Lalla Salma de lutte contre le Cancer 2012.
4. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a 2009; unifying taxonomy? Nat Rev Clin Oncol2009; 6(12): 718-30.
5. Reis-Filho JS, Lakhani SR. Breast cancer special types: why bother? J Pathol 2008; 216: 394
6. Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol Oncol 2010; 4(3): 192-208.
7. Anderson DE, Badzioch MD. Survival in familial breast cancer patients. Cancer 1986;58:360–5.
8. Wobbes T, van de Wiel MP, van der Sluis RF, et al. The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol 1987;13:119–21.
9. Langlands AO, Kerr GR, Bloomer SM. Familial breast cancer. Clin Oncol 1976; 2:41–5.
10. Lynch HT, Albano W, Recerbaren J, et al. Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981;7:1201–9.
11. Lynch HT, Albano WA, Recabaren JA, et al. Survival in hereditary breast and colon cancer. JAMA 1981; 246:1197.
12.Albano WA, Recabaren JA, Lynch HT, et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982; 50:360–3.
13. Malone KE, Daling JR, Weiss NS, et al. Family history and survival of young women with invasive breast carcinoma. Cancer 1996;78: 1417–25.
14. Slattery ML, Berry TD, Kerber RA. Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 1993;4:543–8.
15. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including58209 women with breast cancer and101986 without the disease. Lancet 2001; 358(9291): 1389-99.
16. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: A systematic review and metaanalysis. Int J Cancer 1997; 71(5): 800-9.
17. Molino A, Giovannini M, Pedersini R, et al. Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 2004; 91(1): 96-8.
18.Fukutomi T, Akashi-Tanaka S, Nanasawa T, Matsuo K, Shimizu C. Multicentricity and histopathological background features of familial breast cancers stratified by menopausal status. Int J Clin Oncol 2001; 6(2): 80-3.
19. Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I. Association of family history and other environmental risk factors with breast cancer risk (Sweden). Cancer Causes Control 1998; 9(3): 259-67.
20. Hirose K, Tajima K, Hamajima N, et al. Association of family history and other environmental risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control 2001; 12(4): 349-58.
21. Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception 2009; 80(4): 372-80.
22. Olsson H, Bladström A.A cohort study of reproductive factors and family history of breast cancer in southern Sweden. Breast Cancer Res Treat 2002; 76(3): 203-9.
23. Allen-Brady K, Camp NJ, Ward JH, Cannon- Albright LA. Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 2005; 117(4): 655-661.
24. Fukutomi T, Kobayashi Y, Nanasawa T, Yamamoto H, Tsuda H. A clinicopathological analysis of breast cancer in patients with a family history. Surg Today1993; 23(10): 849-54.
25. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA 1993; 270(3): 338-43.
26. Gavrilov I, Nacheva M, Tzingilev D. Familial breast cancer. Part II: Relationships with histology, staging, steroid receptors and serum tumor markers. J BUON 2002; 7(1): 61-5.
27. Mohammed SN, Smith P, Hodgson SV, et al. Family history and survival in premenopausal breast cancer. Br J Cancer 2008; 77(12): 2252-6.
28. Marcus JN, Watson P, Page DL, Lynch HT. Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr1994; (16): 23-34.
29. Molino A, Giovannini M, Pedersini R, et al. Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 2004; 91(1): 96-8.
30. Yamashita H, Iwase H, Toyama T, et al. Estrogen receptor-positive breast cancer in Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol 2011; 22(6): 1318-132.
31. D'Eredita' G, Giardina C, Napoli A, Troilo VL, Fischetti F, Berardi T. Familial and sporadic breast cancers: differences in clinical, histopathological, and immunohistochemical features. Int J Surg Pathol 2011; 19(6): 724-32.
32. Govindan S, Ahmad SN, Vedicherla B, et al. Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomark 2007; 3(2): 73-8.
33. Russo A, Herd-Smith A, Gestri D, et al. Does family history influence survival in breast cancer cases? Int J Cancer 2002; 99(3): 427-30.
34. Verkooijen HM, Chappuis PO, Rapiti E, et al. Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 2006; 94: 231–238.